Anthony Mato News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Treatment with NX-2127 provides clinically meaningful responses in heavily pretreated chronic lymphocytic leukemia (CLL) patients regardless of Bruton’s...

As severe shortages of fludarabine drag on and prices soar, transplant centers are struggling to cope. The drug is an essential component of stem-cell transplants for some blood cancers.

Learn about some of the most important clinical advances made at MSK in 2021.

Following is a transcript of their remarks: Susan O'Brien, MD: Hi, everyone, and welcome to this roundtable where we're going to discuss CLL presentations at ASH 2020 this year. I'm Dr. Susan O'Brien from the Chao Family Comprehensive Cancer Center at the University of California in Irvine, and I'm joined by two esteemed colleagues, Dr. Jennifer Brown from Dana-Farber and Dr. Anthony Mato from Memorial Sloan Kettering. We have two presentations today on the TRANSCEND clinical trial, and that is an interesting CAR-T trial of liso-cel which targets CD19, like many of the other CAR-Ts, but is a ...

Following is a transcript of their remarks: Susan O'Brien, MD: Hi, everyone, and welcome to this roundtable where we're going to discuss CLL presentations at ASH 2020 this year. I'm Dr. Susan O'Brien from the Chao Family Comprehensive Cancer Center at the University of California in Irvine, and I'm joined by two esteemed colleagues, Dr. Jennifer Brown from Dana-Farber and Dr. Anthony Mato from Memorial Sloan Kettering. An interesting presentation at ASH this year that many people were looking forward to was the trial looking at the combination of what's called U2, which is a novel anti-CD20 a...